Senior EPCM Planner & Scheduler (Primavera, Hybrid)

Jacobs Engineering Group Inc.; Indianapolis (IN); Hybride; USD 85 000 - 145 000; Plein temps

Avantages offerts par ce poste

Health insurance

401(k) plan

Stock purchase program

Unlimited PPTO

Résumé du poste

Jacobs Engineering Group Inc. in the Indianapolis area seeks a driven Planner / Scheduler to support our internal PM/CMs and Life Sciences clients.

You will build integrated CPM schedules from basis documents, lead schedule updates, analyze scheduling data, and ensure earned value alignment across engineering, procurement and construction.

This hybrid role offers opportunities for growth within our global organization and exposure to diverse projects in bioscience and pharma sectors.

Qualifications

• 5+ years of planning/scheduling experience on EPCM projects.
• Minimum of 5 years Primavera software experience.
• Ability to communicate with management, coworkers, clients, vendors, engineers, contractors and visitors.
• Understanding of EPCM project schedules and durations across engineering, procurement, and construction.

Responsabilités

• Build a fully integrated EPCM schedule from scratch using CPM methodology.
• Lead schedule update and review sessions with internal teams.
• Ensure integrity of schedule inputs during updates and look-ahead planning.

Connaissances

Planning / Scheduling

Primavera P6

CPM scheduling

Earned Value Management (EVM)

Schedule Analysis

Effective communication

Outils

Primavera P6 scheduling software

Schedule Analysis tools

Description du poste

Jacobs Engineering Group Inc. in the Indianapolis area seeks a driven Planner / Scheduler to support our internal PM/CMs and Life Sciences clients.

You will build integrated CPM schedules from basis documents, lead schedule updates, analyze scheduling data, and ensure earned value alignment across engineering, procurement and construction.

This hybrid role offers opportunities for growth within our global organization and exposure to diverse projects in bioscience and pharma sectors.